Diabetes Drug Actos May Increase Risk of Bladder Cancer | diabetes
Links shared publicly online about this topic.
- 61total visits
Diabetes Drug Actos May Increase Risk of Bladder Cancer | diabetes
View full resource at diabeticlive.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Bladder Cancer, Urinary System, Drug, Actos
Most Recently Shared on August 19, 2011 at 12:40 pm By:
Diabetes Drug Actos May Increase Risk of Bladder Cancer http://t.co/SWIrJob
Diabetes Drugs Spark Lawsuits Over Cancer Risk | ThirdAge
thirdage.com — “The leader in a new class of diabetes drugs, Actos, has run into the threat of hundreds of lawsuits over allegations that it increases the risk of bladder cancer in patients.” View full resource at thirdage.com
Most Recently Shared on August 9, 2011 at 12:10 am By:
Diabetes Drugs Spark Lawsuits Over Cancer Risk http://bit.ly/rtXqUi
FDA OKs stronger warning for diabetes drug pioglitazone - Related Stories - AANP SmartBrief
smartbrief.com — “The FDA authorized an updated label for diabetes medicines containing pioglitazone, such as Takeda Pharmaceutical's Actos, that includes data on increased risk of bladder cancer in patients treated for more than one year. Also, clinicians are advised against giving such drugs to patients with activ…” View full resource at smartbrief.com
Most Recently Shared on August 8, 2011 at 4:14 pm By:
#FDA OKs stronger #warning for #diabetes drug pioglitazone http://t.co/FzFVw6v #endo
Takeda's Actos diabetes pill needs new cancer-risk warning, Europe says | The Japan Times Online
search.japantimes.co.jp — “Takeda Pharmaceutical Co.'s Actos diabetes drug may be kept on the market with new warnings, the European Medicines Agency said after reviewing research showing the drug carried a slightly increased risk of bladder cancer.” View full resource at search.japantimes.co.jp
Most Recently Shared on July 23, 2011 at 12:52 am By:
Takeda's Actos diabetes pill needs new cancer-risk warning, Europe says: Takeda Pharmaceutical Co.'s Actos diabe... http://bit.ly/nk7vkg
EU urges stricter label for Takeda's diabetes drug Actos - Related Stories - DiabetesPro SmartBrief
smartbrief.com — “The European Medicines Agency said Actos, a diabetes medicine from Takeda Pharmaceutical, can stay on the market but should carry a warning about a small increased risk of bladder cancer. The drug, also known as pioglitazone, remains "a valid treatment option for certain patients with type 2 diabet…” View full resource at smartbrief.com
Most Recently Shared on July 22, 2011 at 4:18 pm By:
#EU urges stricter label for Takeda's #diabetes drug #Actos http://t.co/4eoHhji #risk
Diabetes Drug May Increase Cancer Risk, FDA Says | ThirdAge
thirdage.com — “A diabetes drug currently under development may be linked to bladder and breast cancer, the U.S. Food and Drug Administration says.” View full resource at thirdage.com
Most Recently Shared on July 21, 2011 at 11:25 am By:
Diabetes Drug May Increase Cancer Risk, FDA Says http://bit.ly/oZNIqM
Diabetes Drug May Be Associated With Increase in Risk of Bladder Cancer, July 13, 2011, Stephenson 306 (2): 143 — JAMA
jama.ama-assn.org — “Diabetes Drug May Be Associated With Increase in Risk of Bladder Cancer, July 13, 2011, Stephenson 306 (2): 143 — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on July 14, 2011 at 10:01 pm By:
Pioglitazone an anti diabetic drug may be linkedto bladder cancer http://t.co/O2haHBn
Pulse - Pioglitazone may increase bladder cancer risk, regulator warns
pulsetoday.co.uk — “Pulse - Pioglitazone may increase bladder cancer risk, regulator warns” View full resource at pulsetoday.co.uk
Most Recently Shared on June 30, 2011 at 10:53 am By:
PulseToday Health News and Medical Publisher
Pioglitazone may increase bladder cancer risk, regulator warns: The diabetes drug pioglitazone is under investig... http://bit.ly/mwp2QX
Medical Societies Respond to the FDA’s Safety Announcement on the Use of the Diabetes Medication Actos (pioglitazone) - American Diabetes Association
t.co — “Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” View full resource at t.co
Most Recently Shared on June 20, 2011 at 3:59 pm By:
Kelly / Diabetes Patient Expert
RT @HopeWarsha Response to FDA's 6/15 statement on Actos from ADA, Endo Society & AACE http://t.co/rArN4rc. Nice to see one clear message!
Medical Societies Respond to the FDA’s Safety Announcement on the Use of the Diabetes Medication Actos (pioglitazone) - American Diabetes Association
diabetes.org — “Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” View full resource at diabetes.org
Most Recently Shared on June 20, 2011 at 3:56 pm By:
Hope Warshaw Nutritionist and Dietitian
Combined response to FDA's 6/15 statement on Actos from ADA, Endo Society and AACE http://bit.ly/mLk1bq. How nice to see one clear message!
Diabetes Drug Actos May Raise Risk for Bladder C... ( By Steven Reinberg HealthDay Rep...)
bio-medicine.org — “Health, By Steven Reinberg HealthDay Reporter ...THURSDAY June 16 (HealthDay News) -- The U.S. Food and Drug Administr...The agency's warning comes five days after Germany and France pulled A...The new cancer warning will appear on the labeling the FDA said. ...However although Actos does have some side effects the beneficial e...,Diabetes,Drug,Actos,May,Raise,Risk,for,Bladder,Cancer:,FDA,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine new” View full resource at bio-medicine.org
Most Recently Shared on June 18, 2011 at 1:14 pm By:
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA http://bit.ly/iuGELw
Medical societies respond to the FDA's safety announcement on the use of Actos
medicalxpress.com — “Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. According to the FDA's Safety Announcement, ...” View full resource at medicalxpress.com
Most Recently Shared on June 16, 2011 at 9:07 pm By:
PhysOrg Health News Health News
Medical societies respond to the FDA's safety announcement on the use of Actos http://tw.medicalxpress.com/227462846
Prolonged Use of Diabetes Drug Actos May Increase Risk of Bladder Cancer
onclive.com — “The FDA announced that the prolonged use of pioglitazone (Actos) for more than 1 year has been linked to an increased risk of bladder cancer” View full resource at onclive.com
Most Recently Shared on June 16, 2011 at 9:02 pm By:
FDA Announces That Prolonged Use of Diabetes Drug Actos May Increase Risk of Bladder Cancer http://t.co/yQGYUHv
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration is warning consumers that the popular diabetes drug Actos (pioglitazone) may increase the risk of bladder cancer when used” View full resource at drugs.com
Most Recently Shared on June 16, 2011 at 7:57 pm By:
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA - http://bit.ly/iHvLaF
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration is warning consumers that the popular diabetes drug Actos (pioglitazone) may increase the risk of bladder cancer when used” View full resource at drugs.com
Most Recently Shared on June 16, 2011 at 5:06 pm By:
Drugs and Devices OW OW Health
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA: THURSDAY, June 16 -- The U.S. Food and Drug Ad... http://bit.ly/lPCbAm #drug
Advertisement
